Younossi et al. [101] revealed that A2M and coagulation factor V were highly correlated with NASH-related fibrosis, suggesting that they were potential biomarkers of fibrosis progression. The gene discussed is A2M; the disease is metabolic dysfunction-associated steatohepatitis.